Sequana Medical NV (SEQUA.BR)
EUR 0.72
(3.43%)
EUR 0.72
(3.43%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 548.04 Thousand EUR | -23.68% |
| 2022 | 718.09 Thousand EUR | 144.38% |
| 2021 | 293.83 Thousand EUR | -61.38% |
| 2020 | 760.86 Thousand EUR | -1.55% |
| 2019 | 772.88 Thousand EUR | -11.28% |
| 2018 | 871.11 Thousand EUR | -20.19% |
| 2017 | 1.09 Million EUR | -6.58% |
| 2016 | 1.16 Million EUR | -11.86% |
| 2015 | 1.32 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 39.7 Thousand EUR | 0.0% |
| 2024 Q1 | 39.7 Thousand EUR | -68.53% |
| 2023 Q1 | 147.85 Thousand EUR | 106.04% |
| 2023 Q3 | 126.17 Thousand EUR | 106.49% |
| 2023 Q4 | 126.17 Thousand EUR | 0.0% |
| 2023 Q2 | -1.94 Million EUR | -1414.32% |
| 2023 FY | -4.15 Million EUR | -678.51% |
| 2022 Q2 | -1.49 Million EUR | -930.3% |
| 2022 Q4 | -2.44 Million EUR | -1471.96% |
| 2022 FY | 718.09 Thousand EUR | 144.38% |
| 2022 Q1 | 180.63 Thousand EUR | 110.34% |
| 2022 Q3 | 178.41 Thousand EUR | 111.9% |
| 2021 Q1 | 9006.00 EUR | 100.94% |
| 2021 FY | 293.83 Thousand EUR | -61.38% |
| 2021 Q4 | -1.74 Million EUR | -1367.05% |
| 2021 Q3 | 137.91 Thousand EUR | 108.77% |
| 2021 Q2 | -1.57 Million EUR | -17569.45% |
| 2020 Q4 | -957.93 Thousand EUR | -756.42% |
| 2020 Q3 | 145.93 Thousand EUR | 132.65% |
| 2020 Q1 | 234.5 Thousand EUR | 272.79% |
| 2020 Q2 | -447 Thousand EUR | -290.62% |
| 2020 FY | 760.86 Thousand EUR | -1.55% |
| 2019 FY | 772.88 Thousand EUR | -11.28% |
| 2019 Q4 | -135.71 Thousand EUR | -160.91% |
| 2019 Q3 | 222.82 Thousand EUR | 170.07% |
| 2019 Q2 | -318 Thousand EUR | -294.36% |
| 2019 Q1 | 163.61 Thousand EUR | -43.84% |
| 2018 Q4 | 291.32 Thousand EUR | 27.64% |
| 2018 Q2 | 175.77 Thousand EUR | 0.0% |
| 2018 FY | 871.11 Thousand EUR | -20.19% |
| 2018 Q1 | 175.77 Thousand EUR | -47.04% |
| 2018 Q3 | 228.24 Thousand EUR | 29.85% |
| 2017 Q4 | 331.92 Thousand EUR | 76.2% |
| 2017 Q3 | 188.37 Thousand EUR | 0.0% |
| 2017 FY | 1.09 Million EUR | -6.58% |
| 2016 FY | 1.16 Million EUR | -11.86% |
| 2015 FY | 1.32 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Affluent Medical SA | -1.2 Million EUR | 145.671% |
| Bluelinea Société Anonyme | -3.84 Million EUR | 114.244% |
| Carmat SA | -30.97 Million EUR | 101.77% |
| Diagnostic Medical Systems S.A. | 15.84 Million EUR | 96.541% |
| Euromedis Groupe | 3.57 Million EUR | 84.655% |
| Eurobio Scientific Société anonyme | 53.96 Million EUR | 98.984% |
| Ikonisys S.A. | 255.82 Thousand EUR | -114.226% |
| Implanet S.A. | 3.13 Million EUR | 82.502% |
| Median Technologies SA | -2.55 Million EUR | 121.484% |
| SpineGuard SA | 3.37 Million EUR | 83.781% |
| Theraclion SA | -1.08 Million EUR | 150.727% |
| Euroapi S.A. | 164.6 Million EUR | 99.667% |
| Guerbet SA | 197.14 Million EUR | 99.722% |
| Ion Beam Applications SA | 134.44 Million EUR | 99.592% |
| Koninklijke Philips N.V. | 7.44 Billion EUR | 99.993% |